Chris Holmes
Director, Cancer Clinical Programs, UVM Cancer Center · Robert Larner College of Medicine
Credentials: · · · ·
History
PresentCancer Clinical Programs · Robert Larner College of Medicine
- 1997–1998
- 1989–1993
Research
The platelet contribution to cancer progression
Review · Journal of Thrombosis and Haemostasis · 2011 · 542 citations
Review · Journal of Cellular Physiology · 2014 · Last of 4 authors · 172 citations
JAMA · 2023 · 126 citations
16 papers
14 papers
9 papers · 1 as a fellow
7 papers
7 papers · 2 as a fellow
6 papers
4 papers
4 papers
Grants
- 2021–2025
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
National Cancer Institute · R21
Contact PI · $396.7K · University of Vermont & St Agric College
Clinical trials
- 2022–2024
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
Principal investigator · Unknown
University of Vermont
- 2010–2013
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Principal investigator · Unknown
University of Vermont
- 2009–2018
The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins
Principal investigator · Completed
University of Vermont
- 2008–2012
The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy
Principal investigator · Completed · Early phase 1
University of Vermont